from last year at 12.55% as the company implemented better production cost control for new products that could cause an improvement in production efficiency and could reduce loss in many as aspects. 3
year-ended 31 December 2019 was 197.9 million baht compared to 213.3 million baht the same period last year, decreased 15.4 million baht or 7.2 percent due to an ongoing cost control measures. Over the
December 31, 2019 was Baht 1,530.75, decreased by Baht 133.24 million or 8.01% from last year, driven by the Company was able to control the debt internally both the Company and its subsidiaries. 3
cost. 3) Selling and Administration Expenses Selling and administration expenses decreased by Baht 11.4 million, or 6.5% from Q2/2016, as a result of improved efficiency in cost and expenses control. 4
expenses control. Other Transaction In year 2017 there were Baht 6.2 million from loss on change in fair value less costs to sell of biological assets, Baht 26.3 million and Baht 16.2 million from new office
custodian: (a) System for separating the private fund assets from the custodian’s assets, system for safe keeping of such assets, and internal control system to prevent the misuse of its client’s assets; (b
to operate as a custodian: (a) System for separating the private fund assets from the custodian’s assets, system for safe keeping of such assets, and internal control system to prevent the misuse of
comparing to Q4/2018 loss of Baht 143 million due to higher utilization rate as well as tight costs and expenses control. EBITDA in Q1/2019 was Baht 9 million, a decline of 88% YoY but an 107% upturn QoQ
comparing to Q4/2018 loss of Baht 143 million due to higher utilization rate as well as tight costs and expenses control. EBITDA in Q1/2019 was Baht 9 million, a decline of 88% YoY but an 107% upturn QoQ
the area and the cost control methods had been improved. The company has the cost of sales in the amount 2.33 million baht, compared to the previous year 0.68 million baht, an increase of 1.65 million